Aurinia Pharmaceuticals Income Statement (2018-2025) | AUPH

1Y3Y5Y7Y10YAll
Download Data
Income Statement Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Revenue & cost
Revenue 0.38M0.03M0.22M0.03M0.03M50.00M0.91M6.62M14.67M23.40M21.62M28.19M55.78M28.43M34.41M41.49M54.52M45.09M50.30M57.19M67.77M59.87M62.47M70.01M73.47M
Cost of Revenue 0.05M0.31M0.25M0.48M0.26M1.60M2.45M1.36M0.42M1.56M6.77M5.39M7.75M8.91M6.04M5.55M8.57M7.12M8.18M
Gross Profit 0.87M6.31M14.41M22.92M21.37M26.59M53.33M27.07M33.99M39.93M47.75M39.70M42.55M48.28M61.74M54.31M53.89M62.89M65.29M
Operating items
Amortization - Intangibles 0.30M0.30M0.32M0.40M0.52M0.54M0.52M0.50M
Research & Development 10.86M13.33M12.24M13.17M9.83M10.09M20.07M11.15M4.00M11.53M10.97M9.87M13.16M12.65M13.61M10.23M5.55M4.08M3.05M8.11M5.74M7.43M8.44M
Selling, General & Administrative 3.52M7.43M30.70M40.07M39.80M44.32M44.65M44.76M45.20M51.53M52.17M47.47M50.12M47.08M47.76M50.07M47.70M44.93M42.37M37.03M20.34M26.02M26.18M
Other Operating Expenses 14.11M-1.92M-0.07M0.92M-5.74M-1.77M0.97M-0.06M0.28M-1.43M0.48M0.31M2.17M-0.29M3.63M-2.65M-9.07M4.12M0.29M-4.57M4.51M-4.43M-9.25M-0.93M
Operating Expenses 14.38M34.87M42.34M58.08M51.46M53.75M65.02M56.11M59.51M64.18M65.28M56.53M63.99M57.66M70.78M74.77M63.56M58.70M56.02M61.54M40.62M49.92M43.72M
Operating Income -14.89M-17.14M-24.07M-34.84M-27.06M-26.86M-42.31M-8.05M-50.54M-47.13M-50.35M-32.70M-37.88M-35.99M-9.50M-28.10M-29.58M-16.17M-16.26M-29.67M-13.25M-1.51M11.75M-1.67M21.85M20.08M29.75M
EBIT -18.34M-14.52M-14.89M-17.14M-24.07M-34.84M-27.06M-26.86M-42.31M-8.05M-50.54M-47.13M-50.35M-32.70M-37.88M-35.99M-9.50M-28.10M-29.58M-16.17M-16.26M-29.67M-13.25M-1.51M11.75M-1.67M21.85M20.08M29.75M
Non-operating items
Non Operating Investment Income 0.01M0.01M-0.00M0.00M0.00M0.12M
Interest & Investment Income 0.67M0.47M0.17M0.14M0.17M0.14M0.11M0.11M0.26M0.48M1.46M2.91M3.81M4.10M4.51M4.57M4.53M4.19M4.27M3.99M3.57M3.19M3.32M
Other Non Operating Income -13.93M-0.59M2.98M4.51M-47.99M-9.85M2.95M-2.60M
Non Operating Income -0.56M1.33M
Net income details
EBT -18.34M-14.52M-14.89M-17.14M-19.01M-76.38M-26.17M-26.54M-42.15M-7.92M-50.37M-46.99M-50.25M-32.60M-37.62M-35.51M-8.04M-25.19M-25.77M-12.13M-13.15M-26.42M-10.01M1.48M14.81M1.17M24.35M22.16M31.96M
Tax Provisions 0.09M-0.24M0.00M-0.01M0.16M0.01M0.02M0.01M0.73M0.01M0.01M0.95M0.85M0.44M-0.64M0.30M0.50M0.74M0.80M0.50M-0.30M1.00M0.64M0.41M
Profit After Tax 18.34M-14.59M-14.10M-16.38M-23.45M-34.46M-25.93M-26.54M-42.13M-8.07M-50.38M-47.01M-50.26M-33.32M-37.63M-35.52M-8.99M-26.05M-26.21M-11.49M-13.45M-26.88M-10.75M0.72M14.35M1.43M23.34M21.51M31.55M
Income from Continuing Operations -18.34M-14.52M-14.89M-17.14M-19.01M-76.47M-25.93M-26.54M-42.13M-8.07M-50.38M-47.01M-50.26M-33.32M-37.63M-35.52M-8.99M-26.05M-26.21M-11.49M-13.45M-26.92M-10.75M0.68M14.31M1.47M23.34M21.51M31.55M
Consolidated Net Income -18.34M-14.52M-14.89M-17.14M-19.01M-76.47M-25.93M-26.54M-42.13M-8.07M-50.38M-47.01M-50.26M-33.32M-37.63M-35.52M-8.99M-26.05M-26.21M-11.49M-13.45M-26.92M-10.75M0.68M14.31M1.47M23.34M21.51M31.55M
Income towards Parent Company -18.34M-14.52M-14.89M-17.14M-19.01M-76.47M-25.93M-26.54M-42.13M-8.07M-50.38M-47.01M-50.26M-33.32M-37.63M-35.52M-8.99M-26.05M-26.21M-11.49M-13.45M-26.92M-10.75M0.68M14.31M1.47M23.34M21.51M31.55M
Net Income towards Common Stockholders -18.34M-14.52M-14.89M-17.14M-19.01M-76.47M-25.93M-26.54M-42.13M-8.07M-50.38M-47.01M-50.26M-33.32M-37.63M-35.52M-8.99M-26.05M-26.21M-11.49M-13.45M-26.92M-10.75M0.68M14.31M1.47M23.34M21.51M31.55M
Additional items
EPS (Basic) -0.22-0.17-0.16-0.18-0.25-0.36-0.23-0.24-0.34-0.06-0.40-0.37-0.39-0.25-0.27-0.25-0.06-0.18-0.18-0.08-0.09-0.19-0.070.010.100.010.170.160.24
EPS (Weighted Average and Diluted) -0.23-0.24-0.34-0.06-0.40-0.37-0.39-0.25-0.27-0.25-0.06-0.18-0.18-0.08-0.09-0.19-0.070.010.100.010.160.160.23
Shares Outstanding (Weighted Average) 84.05M84.05M84.05M84.05M85.50M91.65M91.79M94.28M111.80M112.49M112.70M126.45M127.45M128.16M128.40M141.65M141.65M141.74M141.89M142.11M142.58M143.03M143.42M143.61M144.62M143.02M142.99M143.18M137.34M135.10M131.63M
Shares Outstanding (Diluted Average) 118.47M127.40M128.22M128.44M129.37M141.68M141.73M141.86M141.91M142.64M142.90M143.09M143.24M144.01M144.11M145.65M146.19M143.20M140.19M138.96M
EBITDA -18.34M-14.59M-14.89M-17.14M-19.04M-76.47M-25.93M-26.54M-42.13M-8.07M-50.37M-47.00M-50.26M-33.38M-38.40M-35.75M-8.66M-25.58M-26.13M-11.52M-13.37M-26.66M-10.87M0.72M14.82M1.17M23.17M21.43M31.71M
Interest Expenses 0.01M-0.01M0.10M0.07M1.40M1.31M1.28M1.20M1.21M1.15M1.07M1.12M1.10M
Tax Rate 0.91%0.04%5.29%54.13%3.38%4.13%2.90%1.29%